Aurobindo arm’s peptide API unit in Telangana gets 1 USFDA observation | Hyderabad News
Hyderabad: Aurobindo Pharma on Friday informed the stock exchanges that the United States Food and Drug Administration (USFDA) has completed a routine inspection of its subsidiary, Auro Peptides Ltd’s manufacturing facility in Telangana with one observation.The inspection was conducted from August 17 to 21, 2026, at Auro Peptides Ltd, which manufactures peptide active pharmaceutical ingredients,…
